The Evolving Treatment Options for Diabetic Macular Edema

Diabetic retinopathy (DR) is the leading cause of vision loss in working-age adults, and diabetic macular edema (DME) is the most common cause of visual impairment in individuals with DR. This review focuses on the pathophysiology, previous treatment paradigms, and emerging treatment options in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Atul, Varshney, Neeta, Smith, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782842/
https://www.ncbi.nlm.nih.gov/pubmed/24106640
http://dx.doi.org/10.1155/2013/689276
_version_ 1782285618727878656
author Jain, Atul
Varshney, Neeta
Smith, Colin
author_facet Jain, Atul
Varshney, Neeta
Smith, Colin
author_sort Jain, Atul
collection PubMed
description Diabetic retinopathy (DR) is the leading cause of vision loss in working-age adults, and diabetic macular edema (DME) is the most common cause of visual impairment in individuals with DR. This review focuses on the pathophysiology, previous treatment paradigms, and emerging treatment options in the management of DME.
format Online
Article
Text
id pubmed-3782842
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37828422013-10-08 The Evolving Treatment Options for Diabetic Macular Edema Jain, Atul Varshney, Neeta Smith, Colin Int J Inflam Review Article Diabetic retinopathy (DR) is the leading cause of vision loss in working-age adults, and diabetic macular edema (DME) is the most common cause of visual impairment in individuals with DR. This review focuses on the pathophysiology, previous treatment paradigms, and emerging treatment options in the management of DME. Hindawi Publishing Corporation 2013 2013-09-09 /pmc/articles/PMC3782842/ /pubmed/24106640 http://dx.doi.org/10.1155/2013/689276 Text en Copyright © 2013 Atul Jain et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Jain, Atul
Varshney, Neeta
Smith, Colin
The Evolving Treatment Options for Diabetic Macular Edema
title The Evolving Treatment Options for Diabetic Macular Edema
title_full The Evolving Treatment Options for Diabetic Macular Edema
title_fullStr The Evolving Treatment Options for Diabetic Macular Edema
title_full_unstemmed The Evolving Treatment Options for Diabetic Macular Edema
title_short The Evolving Treatment Options for Diabetic Macular Edema
title_sort evolving treatment options for diabetic macular edema
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782842/
https://www.ncbi.nlm.nih.gov/pubmed/24106640
http://dx.doi.org/10.1155/2013/689276
work_keys_str_mv AT jainatul theevolvingtreatmentoptionsfordiabeticmacularedema
AT varshneyneeta theevolvingtreatmentoptionsfordiabeticmacularedema
AT smithcolin theevolvingtreatmentoptionsfordiabeticmacularedema
AT jainatul evolvingtreatmentoptionsfordiabeticmacularedema
AT varshneyneeta evolvingtreatmentoptionsfordiabeticmacularedema
AT smithcolin evolvingtreatmentoptionsfordiabeticmacularedema

Ejemplares similares